GRAIL Galleri Test
$1,250
The Galleri test by GRAIL is a simple blood test that screens for signals linked to over 50 types of cancer, often before symptoms begin. It helps detect cancer early and points to where in the body it may be developing.
Galleri by GRAIL Explained
The Galleri test is a next-generation tool for early cancer detection, designed to catch cancers that often go unnoticed in standard screenings.
With just a single blood draw, the test looks for specific DNA patterns that suggest the presence of cancer in the body. It analyzes small fragments of DNA that circulate in your blood and identifies abnormal changes linked to cancer. If a signal is detected, the test can often indicate where the cancer may have started, helping doctors move quickly with focused follow-up.
It’s a proactive option for those who want more insight into their health before symptoms arise, especially in cases where traditional screening tools fall short.
FAQ
The Galleri® test by GRAIL is a revolutionary multi-cancer early detection blood test that can screen for over 50 types of cancer through a simple blood draw—even before symptoms appear. It’s designed to detect cancer signals in the bloodstream and identify where in the body the cancer may be located.
The test uses advanced next-generation sequencing and machine learning to analyze fragments of DNA (called cell-free DNA) in your blood. It looks for abnormal methylation patterns that are associated with cancer and can determine the potential tissue of origin.
Galleri® can detect a wide range of cancers, including those that are not typically screened for during routine exams, such as:
- Pancreatic cancer
- Ovarian cancer
- Esophageal cancer
- Liver cancer
- Stomach cancer
- Head and neck cancers
- Blood cancers
And many more.
It complements traditional screenings like mammograms, colonoscopies, and pap smears by checking for dozens of other cancers in a single test.
The test is best for individuals who are:
- Aged 40 or older
- Interested in longevity and proactive prevention
- At higher risk due to personal or family history of cancer
- Looking to supplement standard cancer screenings with cutting-edge early detection
The Galleri® test is CLIA-certified and available by prescription, but it is not yet FDA-approved as a standalone diagnostic tool. It is used as a screening tool, and any positive result must be followed up with diagnostic imaging or biopsy to confirm.
Galleri® has a low false-positive rate of less than 1% and can detect cancers even at early stages. While it doesn’t detect every type of cancer 100%, it offers a significant advancement in early detection for cancers that typically go unnoticed until advanced stages.
The magic is in our dosing and protocol. We don’t use a one-size-fits-all model. At TONIIK, we customize the strength, depth, spacing, and frequency of Kenalog injections based on the pattern and severity of your hair loss. This tailored approach delivers better results with fewer side effects.
If a cancer signal is detected, the test provides information about the likely tissue of origin, helping your provider guide you through the next steps for diagnostic testing, such as imaging or biopsy.
At TONIIK, we work closely with you and, if needed, refer you to specialists for further evaluation.
A “no cancer signal detected” result is reassuring, but not a guarantee. You should continue with your regular screenings and health checkups, especially for cancers like skin, cervical, and colorectal that are more effectively detected with standard screenings.
Annual testing is recommended for ongoing cancer surveillance, especially as part of a proactive longevity plan. Like a mammogram or colonoscopy, regular screening improves outcomes through early detection.
Currently, the Galleri® test is not covered by insurance plans. The cost is around $1250, paid out-of-pocket. Many of our patients at TONIIK see it as an investment in their long-term health and peace of mind.
To schedule your Galleri® cancer screening, call us at 818-436-6386 or visit us at TONIIK, 12210 Ventura Blvd, Studio City, CA. Our team will guide you through the process, from pre-screening to follow-up care based on your results.
Call us at 818-436-6386 or visit TONIIK at 12210 Ventura Blvd, Studio City, CA. Our team will assess your hair loss pattern and create a custom treatment protocol designed for your scalp and your goals.
